AKT1 and type 2 diabetes mellitus: Jiangtangxiaoke granules are an effective drug for T2D, since this treatment can regulate the expression of glycogen synthase kinase 3β (GSK3β) by regulating the PI3K/Akt signaling pathway in skeletal muscle of mice with T2D (Yu et al., 2017).